Miscarriage
Conditions
Interventions
Sponsors
Self
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Consenting pregnant women who present with incomplete first trimester miscarriage who are haemodynamically stable
Exclusion criteria
Exclusion criteria: 1. Women in shock 2. Patients with allergy to prostaglandins 3. Those with evidence of genital tract infection 4. Patients with background cardiovascular disease, sickle cell disease or bleeding disorder, liver or renal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be proportion of women with completed uterine evacuation (completed miscarriage) after one week of treatment with MVA or single-dose sublingual misoprostol 400mcg | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the duration of vaginal bleeding after the treatment offered; this will be by asking specific questions on number of days spent having vaginal bleeding, whether she is currently having vaginal bleeding and the woman’s assessment of the severity of the vaginal bleeding on the follow up day 2. To compare the rate of genital tract infection after the treatment. This will involve asking questions on foul smelling vaginal discharge, worsening lower abdominal pain and fever 3. To compare patients’ satisfaction with the treatment method using 5-point Likert scale | — |
Countries
Nigeria
Contacts
Public ContactAbbas Ibrahim
HOD Obstetrics and Gynaecology Federal Teaching Hospital Katsina
Outcome results
None listed